The Pharma Data

FEBRUARY 21, 2022

Re-imagining Radiology. Tackling this challenge with advanced technologies and products, radiology is a key enabler to transform healthcare, expanding personalized medicine and improving outcomes for patients. In particular, AI bears vast potential for advancing radiology.

Radiology 52

Radiology Cardiology Development Production 52

Delveinsight

DECEMBER 29, 2020

Myovant Sciences have decided to put their forces and efforts together to advance the Prostate cancer market as they announced their partnership deal to develop and market relugolix for prostate cancer and women’s health. . Relugolix is a once-daily, oral gonadotropin-release hormone (GnRH) receptor antagonist.

Trials 52

Trials Drugs Hormones Radiology 52

XTalks

JANUARY 19, 2024

Radiobiological and Clinical Considerations from CRO and Emerging Biotech Radiopharmaceuticals are medicinal formulations containing radioisotopes that are used in the field of nuclear medicine primarily for the diagnosis and treatment of various diseases, particularly cancer. There have been more than $1.7 Radiotherapy and Oncology.

DNA 66

DNA Radiology FDA Approval Development 66

The Pharma Data

OCTOBER 14, 2020

“The global heart failure market represents a tremendous opportunity for Sequana Medical and we look forward to providing an update on the interim results from our RED DESERT study later this year.”. Previously, he was Chief of the Heart Failure Section at Duke University School of Medicine from 2013 to 2020. About Dr. Felker G.

Cardiology 40

Cardiology Clinical Trials Clinical Trials Medicine 40